Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
C-MER Eye Care Holdings Limited ( (HK:3309) ) just unveiled an announcement.
C-MER Medical Holdings Limited has called its annual general meeting for 20 May 2026 in Central, Hong Kong, where shareholders will review the audited financial statements for the year ended 31 December 2025 and the reports of the board and auditor. The agenda includes approval of a final dividend of HK2.0 cents per share and a special dividend of HK1.0 cent per share, re-election of five independent non-executive directors, re-appointment of PricewaterhouseCoopers as auditor and a share buy-back mandate allowing repurchases of up to 10% of issued shares, which together underscore the company’s capital return plans and its intention to maintain board stability and financial governance.
If granted, the general mandate to repurchase up to 10% of the company’s issued shares would provide management with additional flexibility in capital management and potential support for the share price. The combination of ordinary and special dividends, along with affirming the existing board composition and auditor, signals confidence in the company’s financial position and continuity in its strategic and oversight framework for stakeholders.
More about C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited is a Hong Kong-listed medical services group focused on providing specialised healthcare, with a particular emphasis on eye and related medical services in the region. The company operates through a network of clinics and medical facilities, targeting patients seeking professional diagnosis, treatment and surgical procedures.
Average Trading Volume: 491,848
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.55B
Learn more about 3309 stock on TipRanks’ Stock Analysis page.